Cytokine-Based Cancer Immunotherapies Summit Boston | Hyatt Regency Boston, MA
Evvnt Promotion / evvnt
Archivo
30.11.2021 - 02.12.2021 Hyatt Regency Boston, 1 Avenue de Lafayette, 02111 Boston, Massachusetts, USA
Time: 8:20 am - 5:00 pm
Temas de la conferencia
Welcome to the only in person dedicated industry forum supporting the development of robust cytokine-based cancer immunotherapy platforms (cytokine muteins, antibody-cytokine fusion proteins (immunokines), anticancer vaccines, and cancer-directed antibodies) to deliver targeted, durable therapeutic interventions to solid tumor and hematological cancer indications.
Welcome to the only in person dedicated industry forum supporting the development of robust cytokine-based cancer immunotherapy platforms (cytokine muteins, antibody-cytokine fusion proteins (immunokines), anticancer vaccines, and cancer-directed antibodies) to deliver targeted, durable therapeutic interventions to solid tumor and hematological cancer indications.
Organizador profesional (PCO)
Hanson Wade
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/850076-3?pid=4832
Speakers: Dario Neri, Co-CEO and CSO, Professor, Philogen and ETH Zurich, Khursheed Anwer, Chief Scientific Officer and Executive Vice President, Celsion and more
Brochure: https://go.evvnt.com/850076-3?pid=4832
Speakers: Dario Neri, Co-CEO and CSO, Professor, Philogen and ETH Zurich, Khursheed Anwer, Chief Scientific Officer and Executive Vice President, Celsion and more
Información e inscripción:
https://go.evvnt.com/850076-1?pid=4832
Ms. Emily Birt
Medicina General, Oncología
Idioma
Inglés
Inglés
Cuota del Congreso
USD 2599.00 - USD 4797.00
USD 2599.00 - USD 4797.00
Los participantes esperaban
1000
1000
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."
